IMMUNOLOGYSUMMIT2025 | Immunology Conference |Top Conference in Immunology | Paris | France | Plenary Speakers | Keynote Speaker | Speaker | Registration

Prof. Wayne W. Hancock

University of Pennsylvania, USA

Title: Will be updated soon

Wayne W. Hancock is a tenured Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Chief of the Division of Transplant Immunology at the Children’s Hospital of Philadelphia. He has long-standing interests in transplant and cancer immunobiology and currently focuses on understanding the biology of Foxp3+ Tregs, with the hope that biochemical, pharmacologic and epigenetic studies of murine and human Tregs might lead to practical ways to regulate their activities. He has published >80 papers on murine and human Tregs and has an H-index of 122.

Prof. Angel Porgador

Ben-Gurion University of the Negev, Israel

Title: Immunotherapy of cancer

Prof. Angel Porgador is the incumbent of the Albert Katz Chair in Cell Differentiation and Malignant Diseases, and a member of the Shraga Segal Department of Microbiology, Immunology and Genetics and the National Institute for Biotechnology in the Negev. He served as Deputy Vice President and Dean for Research and Development until his recent election as the Dean of the Faculty of Health Sciences. Since the outbreak of the coronavirus, Prof. Porgador has led the interdisciplinary Corona Task Force established by BGU President, Prof. Daniel Chamovitz. He also heads a team of University researchers who have developed a new COVID-19 pooling test that identifies all positive subjects, including asymptomatic carriers, in a single round of testing, ultimately helping to prevent the spread of the disease by identifying these patients sooner and at a lower cost using significantly fewer tests. Prof. Porgador is a world renowned researcher in cancer and viral infections. His research focuses on innate immunity of health and disease. In much broader terms, he also investigates prolongation of protein lifespans in a host and the direct killing of tumor cells. He has published more than 130 papers in scientific journals. He holds a B.A with honors in basic medical sciences and an additional B.A in Computer Science and Mathematics from the Hebrew University of Jerusalem. He completed his M.A and Ph.D. in Life Sciences at the Weizmann Institute of Science. His postdoctoral fellowship was at Duke University and the American Institutes of Health (NIH). Porgador has served as President of the Israel Immunological Society and as the President of the Israeli Society for Cancer Research. In his role as Dean, he intends to position the faculty as a leader both in Israel and worldwide, strengthen research and recruit outstanding faculty members. Implementing new and innovative teaching methods is also high on his list of priorities, along with encouraging collaborative research projects, setting up community projects to promote good health and the training of a future generation in the Beer-Sheva spirit.

Prof. Poli Guido

Title: Will be upload soon

After my graduation as M.D in 1982, I joined the Laboratory of Human Immunology (Head: Alberto Mantovani) at the “Mario Negri” Institute for Pharmacological Research in Milano, Italy in 1983 where we published some of the earlier studies on the role of innate immunity in AIDS, an emerging deadly pandemic caused by HIV. In 1986, I moved to the Laboratory of Immunoregulation (Head: Anthony S. Fauci) at the NIAID, NIH, focusing on the role of cytokines as regulators of HIV latency and replication for which we established some of the earliest in vitro models for which I received the NIH Award of Merit in 1992 and the ESCI Award in 1999. In 1994, I was appointed Head of the AIDS Immunopathogenesis Unit (renamed in 2021 as “Human Immuno-Virology, H.I.V.”) at the San Raffaele Scientific Institute in Milano. In 2002, I became Associate Professor of Pathology at the San Raffaele University School of Medicine in Milano (promoted to Full Professor in 2016) while maintaining the role of research Unit Head. I am or have been Associate Editor/Editorial Board of several scientific journals (PlosOne, AIDS, J. of Immunology, Frontiers series, etc.). Thus far, I have authored or co-authored 244 indexed scientific publications plus additional 40 papers (174 original articles and 110 reviews/book chapters/editorials) collecting 11.993 citations and an h-index of 58 (source: Scopus). I have also co-edited two books on “Human Retroviruses. Methods and Protocols” and “HIV Reservoirs. Methods and Protocols” for Springer Protocols (Humana Press) in 2013 and 2022, respectively.

Prof. Devendra K. Agrawal

Western University of Health Sciences, USA

Title: Will be update soon

Dr. Devendra K. Agrawal earned MSc, PhD (Biochemistry), PhD (Medical Sciences), MBA and MS (Information Technology & Management). He has served on several academic positions, including Clinical Biochemist, Professor, Founding Chairman of the Department of Clinical & Translational Science, Senior Associate Dean of Clinical & Translational Sciences, and Senior Vice President for Research and Biotechnology. Currently, Dr. Agrawal is the Professor and Director, Department of Translational Research, Western University of Health Sciences, Pomona, CA, USA. He is also a visiting professor in the Faculty of Medicine at the University of Belgrade, Serbia, University of Banja Luka, Bosnia & Herzegovina, and the University of Kragujevac, Serbia. Dr. Agrawal is a member of the Alpha Omega Alpha Honor Medical Society and is a Fellow of the AAAAI, AHA, APS, and IACS. He has been recognized with many awards, including the highest teaching award at Creighton University, Distinguished Research Career Award, Distinguished Professor Award, Distinguished Faculty Service Award, University Research Award and Distinguished Mentor Award, Professor Bohuslav Ostadal Award for Excellence in Cardiovascular Sciences, Distinguished Leadership Award, Ricardo Gelpi Award, Andras Varro Award, and Harpal Buttar Award for Excellence in Cardiovascular Sciences. Dr. Agrawal has been an invited speaker to many prestigious national and international scientific meetings. Dr. Agrawal is serving on the position of Secretary General and Treasurer of the International Academy of Cardiovascular Sciences - North American section, and the Director and Treasurer of the Academy of Cardiovascular Sciences Foundation USA, Inc. Dr. Agrawal has served on many grants review panels, including VA Merit Review, DoD, NIH-NIAID, NIH-NHLBI, MRC-UK and US-Israel BSF Grant Review Committees, Science Foundation Ireland, Austrian Science Fund, British Lung Foundation, Swiss NSF, ViCi Netherlands, and Asthma Research Foundation of Western Australia. Dr. Agrawal has served on the editorial board of several prestigious journals. Dr. Agrawal contributed to science by publishing >560 original research articles in peer-reviewed journals and book chapters. He has co-edited books in Allergy, Asthma, and Immunology, COVID19 and Stem Cells, Flow Cytometry, and Environmental Factors in the Pathogenesis of Cardiovascular Diseases. His major research areas include the cellular, molecular and immunobiology of diabetes and diabetic foot ulcers, renal diseases, allergy and bronchial asthma, vascular diseases, shoulder rotator cuff injuries, and traumatic brain injury. NIH funds his research projects. Dr. Agrawal has trained >200 medical students (who are now academic physician-scientists), directly supervised and guided 72 graduate students to earn MD-PhD, MD-MS, MS, and Ph, degrees, 75 post-doctoral fellows, 15 assistant professors, many of whom are currently on high positions in academia and industries. Many clinical residents, fellows and research investigators have received training under his direct supervision. He is passionate to train and mentor next generation of clinical and translational researchers.

Dr. Hassan Abolhassani

Karolinska Institutet, KI, Sweden

Title: Autoimmunity associated with Actin-related Inborn Errors of Immunity

Dr. Hassan Abolhassani is an Assistant Professor of Clinical Immunology at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, KI, Sweden. He obtained his MD and MPH at the Tehran University of Medical Sciences and his PhD in Immunogenetics at KI. During his Post-doc he evaluated single-cell multi-omics of novel Inborn Errors of Immunity (IEI) after he obtained the Jonas Söderquist award for the best PhD thesis at KI. He is currently the president of the Middle East and North Africa Registry on IEI (MENA-IEI), one of the largest cohorts worldwide (>17000 patients) performing translational research on immune defects and specific IEI with B cell defects and immune dysregulation. He is a steering member of the J Project experts (professional network on IEI and related diseases in East-European countries) and a distinguished clinical immunologist collaborator of Global Burden of Disease (GBD). Additionally, he is a leading member of the junior faculty at KI and received several awards including Anna-Greta Craford's prize, Barlan Award, Razi Research Festival, and USERN LAUREATES in Medical Sciences. Within a long-term collaboration with the Center for Vaccine Equity, and Task Force for Global Health, he is coordinating the guidelines for diagnosis, treatment, transplantation and vaccinations in IEI patients. Fortunately, he is honored as top 1% of highly cited scientific researchers in the field of Immunology, Essential Science Indicators (ESI, Web of Science) and the World's Top 2% widely cited scientists based on Stanford University.